124 related articles for article (PubMed ID: 10514348)
1. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient.
Kristmundsdóttir T; Arnadóttir SG; Bergsson G; Thormar H
J Pharm Sci; 1999 Oct; 88(10):1011-5. PubMed ID: 10514348
[TBL] [Abstract][Full Text] [Related]
2. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro.
Thormar H; Bergsson G; Gunnarsson E; Georgsson G; Witvrouw M; Steingrímsson O; De Clercq E; Kristmundsdóttir T
Sex Transm Infect; 1999 Jun; 75(3):181-5. PubMed ID: 10448397
[TBL] [Abstract][Full Text] [Related]
3. Development of a virucidal cream containing the monoglyceride monocaprin.
Thorgeirsdóttir TO; Hilmarsson H; Thormar H; Kristmundsdóttir T
Pharmazie; 2005 Dec; 60(12):897-9. PubMed ID: 16398264
[TBL] [Abstract][Full Text] [Related]
4. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides.
Bergsson G; Arnfinnsson J; Karlsson SM; Steingrímsson O; Thormar H
Antimicrob Agents Chemother; 1998 Sep; 42(9):2290-4. PubMed ID: 9736551
[TBL] [Abstract][Full Text] [Related]
5. Effect of buffers on the properties of microbicidal hydrogels containing monoglyceride as the active ingredient.
Kristmundsdóttir T; Sigurdsson P; Thormar H
Drug Dev Ind Pharm; 2003 Feb; 29(2):121-9. PubMed ID: 12648008
[TBL] [Abstract][Full Text] [Related]
6. Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: impact on the search for vaginal microbicides.
Neyts J; Kristmundsdóttir T; De Clercq E; Thormar H
J Med Virol; 2000 May; 61(1):107-10. PubMed ID: 10745241
[TBL] [Abstract][Full Text] [Related]
7. Virucidal activities of medium- and long-chain fatty alcohols, fatty acids and monoglycerides against herpes simplex virus types 1 and 2: comparison at different pH levels.
Hilmarsson H; Kristmundsdóttir T; Thormar H
APMIS; 2005 Jan; 113(1):58-65. PubMed ID: 15676016
[TBL] [Abstract][Full Text] [Related]
8. Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens.
Talwar GP; Raghuvanshi P; Mishra R; Banerjee U; Rattan A; Whaley KJ; Zeitlin L; Achilles SL; Barré-Sinoussi F; David A; Doncel GF
Am J Reprod Immunol; 2000 Mar; 43(3):144-51. PubMed ID: 10735590
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides.
Bergsson G; Steingrímsson O; Thormar H
Antimicrob Agents Chemother; 1999 Nov; 43(11):2790-2. PubMed ID: 10543766
[TBL] [Abstract][Full Text] [Related]
10. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels.
Hilmarsson H; Traustason BS; Kristmundsdóttir T; Thormar H
Arch Virol; 2007; 152(12):2225-36. PubMed ID: 17891329
[TBL] [Abstract][Full Text] [Related]
11. Killing of Gram-positive cocci by fatty acids and monoglycerides.
Bergsson G; Arnfinnsson J; Steingrímsson O; Thormar H
APMIS; 2001 Oct; 109(10):670-8. PubMed ID: 11890570
[TBL] [Abstract][Full Text] [Related]
12. Stable concentrated emulsions of the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the food-borne bacteria Campylobacter jejuni, Salmonella spp., and Escherichia coli.
Thormar H; Hilmarsson H; Bergsson G
Appl Environ Microbiol; 2006 Jan; 72(1):522-6. PubMed ID: 16391087
[TBL] [Abstract][Full Text] [Related]
13. Effects of polysorbates on antiviral and antibacterial activity of monoglyceride in pharmaceutical formulations.
Thorgeirsdóttir TO; Thormar H; Kristmundsdóttir T
Pharmazie; 2003 Apr; 58(4):286-7. PubMed ID: 12749415
[No Abstract] [Full Text] [Related]
14. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
Neurath AR; Strick N; Li YY; Lin K; Jiang S
Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
[TBL] [Abstract][Full Text] [Related]
15. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
[TBL] [Abstract][Full Text] [Related]
16. Monocaprin eye drop formulation to combat antibiotic resistant gonococcal blindness.
Churchward CP; Al-Kinani AA; Abdelkader H; Swinden J; Siwoku O; Varnakulasingam T; Alany RG; Snyder LAS
Sci Rep; 2020 Jul; 10(1):12010. PubMed ID: 32694582
[TBL] [Abstract][Full Text] [Related]
17. Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance.
Churchward CP; Calder A; Snyder LAS
PLoS One; 2018; 13(4):e0195453. PubMed ID: 29621310
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate).
Zaneveld LJ; Waller DP; Anderson RA; Chany C; Rencher WF; Feathergill K; Diao XH; Doncel GF; Herold B; Cooper M
Biol Reprod; 2002 Apr; 66(4):886-94. PubMed ID: 11906905
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.
Thormar H; Isaacs CE; Brown HR; Barshatzky MR; Pessolano T
Antimicrob Agents Chemother; 1987 Jan; 31(1):27-31. PubMed ID: 3032090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
